Aging is a process of gradual decline in physical and cognitive function and is a major risk factor for mortality. Despite the increasing number of relevant studies, the mechanisms regulating the aging process have not been fully elucidated. Genetic factors have long been recognized as key factors in controlling the rate of aging. Testes‐specific protease 50 (TSP50) has been shown to be involved in the regulation of embryonic development and intestinal homeostasis, but its role in the regulation of aging remains unclear. Here, we showed that TSP50 expression was reduced in the hippocampus of both aged humans and mice. TSP50 deficiency in neural stem cells (NSCs) drove accelerated aging in mice, characterized by exacerbated age‐related cognitive impairments and significantly elevated neuroinflammation. Notably, aged mice with NSCs‐specific knockout of TSP50 exhibited impaired intestinal mucosal barriers, dysbiosis of gut microbiota, and a marked reduction in the production of short‐chain fatty acids (SCFAs). Restoring gut microbial ecology using fecal microbiota transplantation (FMT) and overexpressing TSP50 successfully alleviated aging‐associated cognitive decline and neuroinflammation. Taken together, our study suggests that TSP50 plays a critical role in the aging process and identifies gut microbiota as a pivotal mediator of TSP50's influence on age‐related cognitive decline and neuroinflammation. These findings highlight the potential therapeutic value of targeting TSP50 and gut microbiota for aging, offering insights into aging mechanisms and interventions for aging‐related neurodegenerative diseases.
Mouse intestinal organoids are essential 3D models that retain host genetic characteristics and complex architecture, making them invaluable for intestinal biology research. However, traditional cultivation and histological processing often suffer from high operational complexity and sample loss during sectioning. This protocol provides an optimized workflow for the establishment of mouse intestinal organoid cultures and their subsequent preparation for immunohistochemistry and fluorescence staining. By refining the handling steps, the method significantly reduces total operational time while enhancing experimental quality. Furthermore, the protocol addresses common challenges in structural integrity, ensuring that the delicate crypt-villus morphology remains intact during the sectioning process. This comprehensive approach offers a robust framework for high-quality histological analysis, supported by a comparative evaluation with traditional methods to guide researchers in different experimental contexts. • Introduces a direct pellet-OCT embedding strategy that minimizes organoid transfer and sample loss during histological processing. • Enables high-quality frozen sections compatible with H&E, Alcian Blue, immunohistochemistry, and immunofluorescence staining. • Provides a practical alternative to conventional agarose-paraffin workflows while preserving organoid morphology and reducing processing complexity.
The multifaceted oncogenic role of teratocarcinoma-derived growth factor 1 (TDGF1) in colon cancer remains incompletely understood. Through integrative bioinformatic and functional analyses, we identified a novel competing endogenous RNA (ceRNA) axis wherein the long non-coding RNA OLMALINC directly sponges hsa-miR-3614-5p, leading to the derepression of TDGF1. This OLMALINC/miR-3614-5p/TDGF1 axis promoted colon cancer cell proliferation, migration, invasion, and anti-apoptosis in vitro, whereas TDGF1 knockdown significantly suppressed tumor growth in vivo. Mechanistically, TDGF1 co-activated oncogenic signaling via the Thr88-dependent Nodal/Smad2 cascade and the Glypican-1-mediated MAPK/AKT pathway. Beyond cell-autonomous effects, transcriptomic and single-cell analyses revealed that elevated TDGF1 correlates with an immunosuppressive microenvironment, characterized by reduced immune infiltration and altered LGALS9-CD44 malignant-T cell communication. Clinically, high TDGF1 expression in a tissue microarray cohort was significantly associated with advanced T stage, reduced expression of specific mismatch repair proteins (MLH1/PMS2), and poor overall survival. Collectively, this study delineates the OLMALINC/miR-3614-5p/TDGF1 regulatory circuit and establishes TDGF1 as a multifaceted driver of tumor progression, highlighting its potential as a prognostic biomarker and therapeutic target in colon cancer.